Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that’s when a drug is prescribed for something it’s not FDA-approved for.

The plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...